E-Books durchsuchen

Diagnosis and Management of Hypertrophic Cardiomyopathy [2004]

1
Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy
37
Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy
67
Genetic Basis and Genotype‐Phenotype Relationships in Familial Hypertrophic Cardiomyopathy
81
Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
95
Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management
105
Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy
121
Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy
132
Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance
147
Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions
158
Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy
172
Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy
185
Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression
195
Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy
200
Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy
220
Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy
236
United States Perspectives on the Role of Dual‐Chamber Pacing in Patients With Hypertrophic Cardiomyopathy
246
Dual‐Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy
259
Alcohol Septal Ablation
279
Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven‐Year Experience
297
Role of Septal Ablation in a Surgical Center
307
Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy
319
Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hyptertrophy as a New Indicator of Risk
327
Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy
345
Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and not so Benign Arrhythmias
367
The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies
382
Importance of Congenital Coronary Artery Anomalies
393
Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program
404
Cardiovascular Causes of Sudden Death, Preparticipation Screening, and Criteria for Disqualification in Young Athletes
432
Sudden Death Due to Chest Blows (Commotio Cordis)
448
Naturally Occurring Animal Models of Cardiovascular Disease Causing Premature Death
473
The Role of the Internet and Patient Support Groups for Those Living with Hypertrophic Cardiomyopathy
481
Afterword
487
Index
i
Frontmatter
Feedback